Ribavirin (CAS 36791-04-5), C8H12N4O5, the formula weight is 244.2, and its form is white solid.
Ribavirin is used to prevent parainfluenza, hepatitis A, hepatitis B, hepatitis C, measles, mumps, chickenpox, herpes simplex, herpes zoster, viral keratitis, herpetic stomatitis, and pediatric adenovirus pneumonia.

The global Ribavirin (CAS 36791-04-5) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Ribavirin (CAS 36791-04-5) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ribavirin (CAS 36791-04-5) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Ribavirin (CAS 36791-04-5) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Eye Drop
Oral

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Sine Pharma
Chengyi Pharma
Hengruida Pharma
Sun Flower
Yatai Pharma
Biokin Pharma
South China Pharma
Mysun Pharma
Pinnacle Pharma
Zydus Cadila
Roche
Apazer
Cipla